Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed Zahidi has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Hanane Benzeid

    Laboratory of Analytical Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco

    6 shared publications
  • A Cheikh

    Abulcasis University, Faculty of Pharmacy, Rabat- Morocco, Morocco

    4 shared publications
  • Daniel Fourmy

    Institut National de la Santé et de la Recherche Médicale Unité 151, Centre Hospitalier Universitaire de Rangueil, Toulouse

    4 shared publications
  • Khadija Khedid

    4 shared publications
  • Lucien Pradayrol

    Institut National de la Santé et de la Recherche Médicale Unité 151, Centre Hospitalier Universitaire de Rangueil, Toulouse

    4 shared publications
  • M Bouatia

    Mohammed V University-, Faculty of Medicine and Pharmacy- Paediatric Hospital- Pharmacy-, Rabat, Morocco

    4 shared publications

Latest Publications

  • Open Access

    Systemic Phagocytic Activity and Topical Repair Effects of Pelargonium graveolens L’Hér Extract with Reduced Nociceptive Response: In Vivo Models

    by Najlae El-Otmani, Rania Akoh, Fadoua El Ouazzani, Rabab Ouazzani, Hayat Ben-Saghroune, Jwaher Haji Alhaji, Layla Tahiri Elousrouti, Laila Chbani, Noorah A. Alkubaisi, Pu Xia, et al.

    Background: Pelargonium graveolens is traditionally used for its anti-inflammatory and wound-healing properties. However, its effects on phagocytosis, nociception, and tissue repair remain poorly characterized. Methods: Polysaccharides were identified in the extract. Tyrosinase, elastase, and collagenase inhibitory activities were evaluated in vitro. Systemic phagocytosis was assessed by the carbon clearance assay in rats (n = 6/group; oral extract, 300 and 600 mg/kg for 12 days). Anti-inflammatory and antinociceptive activities were evaluated using carrageenan-induced paw oedema (n = 5/group; topical 3% and 6% cream) and plantar thermal tests (n = 6/group), respectively. Wound healing was evaluated separately using only the topical 6% cream for 15 days in rats (n = 6/group; topical 6% cream), followed by histopathological evaluation. Results: The extract contained D-glucose (72.76 ± 3.64 µg/mL) and polysaccharides (2.89 ± 1.55 mg GE/g DE). It inhibited tyrosinase (IC50 = 340.80 ± 28.61 µg/mL), elastase (IC50 = 761.67 ± 14.62 µg/mL), and collagenase (IC50 = 456.55 ± 6.14 µg/mL) in a concentration-dependent manner. Phagocytic activity increased, reaching a phagocytic index of 0.023 ± 0.005 at 600 mg/kg. Topical 3% and 6% creams were evaluated for anti-inflammatory activity, with the 6% cream showing the highest effect (83.36 ± 0.78% inhibition at 240 min) and increased paw withdrawal latency (4.10–4.35 s at 90 min). The 6% cream was associated with progressive wound contraction, reaching 79.01 ± 43.64% by day 9. However, after adjustment for baseline wound area, no statistically significant overall treatment effect was detected. Histopathological analysis showed greater collagen deposition, vascularization-associated histological features, and re-epithelialization in the treatment group compared with the vehicle group. Conclusions: Oral administration enhanced systemic phagocytic activity, while topical application produced anti-inflammatory and antinociceptive effects. The 6% formulation showed promising wound-healing effects, although no statistically significant overall treatment effect was detected after adjustment for baseline wound area. Further studies are warranted to elucidate the underlying mechanisms and establish the safety profile of the formulations.

  • Open Access

    Dermatological Application of Pelargonium graveolens Flower: A Novel Potential Source of Melanin Synthesis-Inhibiting Effects

    by Najlae El-Otmani, Mohamed Chebaibi, Ahmed Zahidi

    The increasing prevalence of skin-aging and pigmentation disorders, along with inflammation-related pathologies, has driven the search for novel enzyme inhibitors with targeted action against key enzymes such as elastase, collagenase, and tyrosinase. In this context, extracts from Pelargonium graveolens (P. graveolens) flowers were subjected to in vitro and in silico assays to evaluate their inhibitory effects on theses enzymes, as well as the BSA protein denaturation. Additional assessments of emulsification and photoprotective properties were conducted. The hydroethanolic sonication extract demonstrated potent therapeutic potential, with low IC50 values for BSA denaturation (0.31 ± 0.26 mg/mL), tyrosinase (0.06 ± 0.04 mg/mL), elastase (1.29 ± 0.58 mg/mL), and collagenase (0.28 ± 0.14 mg/mL). All extracts effectively reduced surface and interfacial tension, highlighting their potential as natural co-emulsifier. HPLC-PDA-MS/MS analysis identified key bioactive compounds, including shikimic acid, gallic acid diglucoside, and salvianolic acid M. In fact, Binding site prediction revealed that shikimic acid and dihydroxybenzoic acid from P. graveolens extract are likely the key compounds responsible for the inhibitory effects on elastase, collagenase, and tyrosinase. Additionally, trigallic acid appears to play a major role in the inhibition of BSA denaturation. Stability tests of novel formulations-based 2% P. graveolens supporting their potential for commercial applications.

  • Open Access

    Evaluation of the content of polyphenols, flavonoids, tannins, antioxidant capacity and antibacterial activity of Pelargonium graveolens flower extracts

    by El-Otmani Najlae, Zeouk Ikrame, Ben-Saghroune Hayat, Zahidi Ahmed

    Pelargonium graveolens has garnered attention for its therapeutic properties, especially in treating dermatological conditions. The aim of this study was to investigate the phytochemicals, antioxidant action and antibacterial effect of its flower extracts obtained through maceration, sonication and infusion. The findings show that the highest total phenolic content was obtained from the hydroethanolic sonication extract (280.39 mg GAE/g), followed by the hydroethanolic maceration extracts (272.87 mg GAE/g). The total flavonoid content varied from 21.51 mg EQ/g (hydroethanolic maceration) to 12.32 mg EQ/g (aqueous infusion). Condensed tannins were highest in the hydroethanolic maceration extracts (8.40 mg/mL). Additionally, the antioxidant action was assessed using the DPPH, FRAP, TAC and ABTS methods. The extracts from hydroethanolic sonication showed a high free radical scavenging capacity (IC50 = 0.31 mg/mL) compared with extracts from aqueous infusion and hydroethanolic maceration. However, antibacterial tests revealed that all extracts had better activity against Gram-positive bacteria. The hydroethanolic maceration extracts showed pronounced sensitivity, exhibiting zones of inhibition ranging from 13 to 24 mm for Gram-negative bacteria and 19 to 24 mm for Gram-positive bacteria. These extracts demonstrated significant efficacy against methicillin-resistant Staphylococcus aureus and Panton-Valentine Leukocidin-Positive Staphylococcus aureus. These findings suggest potential applications in the pharmaceutical and dermatological fields, particularly for developing natural antioxidant and antibacterial agents.


  • Open Access

    Formulation of Biological Sunscreen from Calendula arvensis Capitula Extracts: Antioxidant, Anti-Aging, Surface Tension, and UVB Protection Properties Assessed

    by Najlae El-Otmani, Ikrame Zeouk, Ahmed Zahidi

    Skin protection against ultraviolet (UV) radiation has long been crucial due to its role in photoaging, sunburn, and wrinkles. This study focuses on developing a bio-based sunscreen from Calendula arvensis capitula extract. Various extraction methods (maceration, sonication, and infusion) and solvents (EtOH, EtOH-H2O, and H2O) were explored in order to identify the most effective extract for use in a sunscreen formulation. Each extract was analyzed for its phenolic content, as well as antioxidant activities (assessed through DPPH, CAT, and FRAP assays). Enzyme inhibition assays for tyrosinase, elastase, and collagenase highlighted the low IC50 values of the hydroethanolic extract. Furthermore, the in vitro sun protection factor (SPF) against UVB radiation was measured using ultraviolet spectrophotometry. A phytochemical analysis showed phenolic levels between 8 and 27 mg GAE/g, flavonoid concentrations of 7–13 mg QE/g, and tannin levels of 1.15–1.68 mg/mL, alongside moderate antioxidant activity. The ethanol maceration extract reduced the interfacial tension to 2.15 mN/m in 600 s, outperforming the conventional emulsifier polysorbate 20. The sonicated hydroethanolic extract demonstrated remarkable SPF efficacy (SPF = 193.65 ± 0.02), far exceeding that of the standard zinc oxide (SPF = 11.88 ± 0.03). The proposed formulations meet the COSMOS standards, suggesting their potential for certification as biological products. Further clinical and in vivo studies are necessary to confirm their safety and commercial viability.


  • Open Access

    Assessment of Pelargonium graveolens flower essential oil: Antimicrobial, antioxidant, enzyme inhibition and in vivo topical analgesic and anti-inflammatory efficacy as treatment for atopic dermatitis

    by Najlae El-Otmani, Fadoua el Ouazzani, Rania Akoh, Rabab Ouazzani, Ikrame Zeouk, Abdellatif Loukili, Dalila Bousta, Ahmed Zahidi

    Background Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by pruritus and skin barrier dysfunction. This study aims to evaluate the therapeutic potential of Pelargonium graveolens (Geraniaceae) in managing AD symptoms through its essential oil. Methods The chemical composition of Pelargonium graveolens flower essential oil (PFEO) was analyzed using gas chromatography-mass spectrometry (GC-MS). Its antimicrobial, antioxidant, and anti-inflammatory properties were assessed, along with the inhibitory effects of PFEO on key enzymes involved in skin repair: tyrosinase, elastase, and collagenase. An in vivo evaluation of a gel formulation containing PFEO was also conducted to assess its anti-inflammatory and analgesic efficacy. Results GC-MS analysis identified major compounds in PFEO, including Geraniol (22.83%), beta-citronellol (19.51%), naphthalenemethanol (15.36%), and Geranyl tiglate (9.38%), with minor constituents such as linalool (3.81%) and neryl formate (1.31%). PFEO exhibited bacteriostatic activity against various bacterial and fungal strains, including Pseudomonas aeruginosa, Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), Bacillus anthracis, Streptococcus pyogenes, Staphylococcus epidermidis, Candida albicans, and Malassezia spp. The essential oil also demonstrated significant antioxidant properties and inhibited key enzymes linked to skin alterations in AD. Conclusions PFEO shows promising therapeutic potential for managing symptoms of atopic dermatitis due to its antimicrobial, antioxidant, and anti-inflammatory properties, as well as its analgesic effects. The findings support further exploration of PFEO as a natural alternative in the treatment of AD.


  • Open Access

    Analysis and Quality Control of Bio-actives and Herbal Cosmetics: The Case of Traditional Cooperatives from Fes-Meknes Region

    by Najlae El-Otmani, Ikrame Zeouk, Othmane Hammani, Ahmed Zahidi

    Consumers are increasingly turning to organic cosmetic products. Faced with this enthusiasm, many cooperatives have specialized in biocosmetics. This study aims to analyze the operational strategies of 25 cooperatives involved in natural ingredient cultivation and cosmetics formulation, through extensive surveys and interviews, the study seeks to elucidate market positioning, product offerings, and consumer preferences among these cooperatives. Financial reliance on personal resources, impediments to certification processes, and consumer shopping preferences are among the primary objectives explored. The results reveal that a significant majority (66%) of cooperatives depend on personal finances, with financial constraints hindering certification efforts and impacting sales. Consumer preferences favor traditional retail outlets like supermarkets and parapharmacies over online platforms. Quality labels and dermatological advice emerge as pivotal factors influencing consumer purchasing decisions. Furthermore, a randomized sample assessment evaluates product quality, encompassing sensory, microbiological, and physical stability tests, alongside heavy metal contamination analysis via the Inductively Coupled Plasma Atomic Emission Spectroscopy method. Cream formulations exhibit variable stability, with water activity significantly affecting microbial growth; products with lower water content demonstrate enhanced stability. Additionally, hydrolat quality profiles display varying levels of microbiological contamination, while essential oils demonstrate moderate quality with fluctuating acidity levels. This research sheds light on the operational dynamics of cooperatives within the natural products sector, offering insights into market dynamics, product quality, and consumer preferences. The findings underscore the imperative of resource optimization, certification facilitation, and consumer education in enhancing cooperative competitiveness and sustainability within the natural products market.


  • Open Access

    Evaluation of the content of polyphenols, flavonoids and tannins, the antioxidant capacity, and the antimicrobial activity of different organic and aqueous fractions of stems of Retama monosperma

    by Fatima Zahra Benkhouili, Amina Moutawalli, Lahcen Ouchari, Elmostafa El Fahime, Hanane Benzeid, Anass Doukkali, Ahmed Zahidi

    Publish research papers from all areas of plant science


  • Open Access

    Quantitative phytochemical, antioxidant and antimicrobial properties of the seeds of Lawsonia inermis L.

    by Amina Moutawalli, Fatima Zahra Benkhouili, Lahcen Ouchari, Elmostafa El Fahime, Hanane Benzeid, Anass Doukkali, Ahmed Zahidi

    Lawsonia inermis, commonly known as Henna, is a plant that has been extensively utilized throughout the ages for its medicinal and cosmetic properties. This plant contains a variety of bioactive compounds and has attracted significant interest due to its potential antioxidant and antimicrobial activities. The aim of our study is to evaluate the antioxidant capacity and antibacterial activity of Lawsonia inermis seeds. L. inermis seed powder was extracted using hexane, dichloromethane, ethanol and water. The 4 fractions were quantified for polyphenols, flavonoids and tannins contents. The antioxidant capacity was assessed using 4 methods: 2,2?-Diphenyl- picrylhydrazyl hydrate (DPPH) , 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic) (ABTS), Ferric Reducing Antioxidant Power (FRAP), and Phosphomolybdate assay (PMA). Antimicrobial activity was determined by agar diffusion against Staphylococcus aureus, Bacillus cereus, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. The liquid dilution method was used to determine the minimum inhibitory concentration, minimum bactericidal concentration and minimum fungicidal concentration. The highest content of polyphenols and tannins was obtained in the ethanolic fraction, with values of 594.01±6.07 mg GAE/g dw and 242.4±1.6 mg CE/g dw respectively. The ethanolic fraction exhibited significant scavenging of free radicals (DPPH) with an IC50 of 3.06±0.01 µg/mL, lower than the IC50 of the standard quercetin (5.30±0.02 µg/mL). Moreover, the ethanolic fraction showed antimicrobial activity against S. aureus, B. cereus and E. faecalis strains, with zone of inhibition values of 15.5±0.7, 14.0±0.0 and 14.5±0.7 mm respectively. The minimum inhibitory concentration of the ethanolic fraction was found to be 1.563 mg/mL against both S. aureus and B. cereus strains, while the minimum bactericidal concentration was 3.125 mg/mL against B. cereus and 6.25 mg/mL against E. faecalis strains. L. inermis seeds exhibit significant antioxidant capacity and demonstrate antimicrobial activity. These findings indicate the potential of L. inermis seeds as a valuable source of bioactive compounds with antioxidant and antimicrobial properties.


  • Open Access

    Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions

    by Soufiane Drioua, Mouna Ameggouz, Amine Assouguem, Mohammed Kara, Riaz Ullah, Ahmed Bari, Rachid Lahlali, Hafize Fidan, Otman El-Guourrami, Fatima Zahra Benkhouili, et al.

    Chenopodium ambrosioides aerial parts have been historically employed in traditional medicine for addressing various ailments such as headaches, abdominal discomfort, joint issues, and respiratory disorders, alongside treatments for lice and warts. This study aimed to conduct a comprehensive phytochemical analysis of C. ambrosioides and assess the acute and subacute toxicity of oral treatments using fractions in preclinical trials. Spectrophotometric analysis via LC–MS/MS was used to characterize the plant’s chemical composition. Acute toxicity evaluation followed Organisation for Economic Co-operation and Development code 42 guidelines, conducted on adult male and female Wistar strain mice. Subsequently, Swiss mice were divided into six groups for the subacute toxicity study, receiving oral doses of 200 mg/kg extracts and fractions for 28 days. Daily observations and biochemical analyses were performed, with LC–MS/MS revealing a diverse array of compounds including organic acids, flavonoids, phenolic acids, rutin, hesperidin, nicotiflorine, and fumaric acid. Results indicated no lethality or alterations in body weight in treated groups, though some organ weight changes were noted. Biochemical analyses demonstrated values within the normal range for all groups, suggesting that the treatments did not induce adverse effects. Acute and subacute treatments with fractions did not result in lethality or toxic alterations at therapeutic doses, implying the safety of the product at appropriate levels. This study underscores the potential of C. ambrosioides as a safe therapeutic option warranting further exploration.


  • Open Access

    Phytochemical study, antioxidant activity, and dermoprotective activity of Chenopodium ambrosioides (L.)

    by Soufiane Drioua, Otman El-Guourrami, Amine Assouguem, Mouna Ameggouz, Mohammed Kara, Riaz Ullah, Ahmed Bari, Ahmed Zahidi, Azra Skender, Hanane Benzeid, et al.

    Chenopodium ambrosioides, a member of the Chenopodiaceae family, is renowned for its toxic properties. Despite its toxicity, it has been traditionally utilized in various communities, particularly in pediatric contexts, for its vermifuge, antispasmodic, and antipyretic attributes. This study aims to unravel the phytochemical composition present in organic fractions and aqueous extracts obtained from the aerial components of C. ambrosioides. Furthermore, our objective is to evaluate the antioxidant activity of these extracts and fractions, coupled with a comprehensive examination of their toxicological effects. Polyphenols were quantified using the Folin–Ciocalteu reagent, flavonoids via the aluminum trichloride reagent AlCl3, and tannins using the vanillin method. Identification of bioactive compounds within the plant specimen was accomplished through GC-MS spectrophotometric analysis. The assessment of antioxidant activity employed DPPH, ferric (Fe3+) ion antioxidant reducing power (FRAP), ABTS, and TAC methods, with quercetin, catechin, and ascorbic acid serving as standards. Dermoprotective activity was studied using the ultraviolet absorption test. The GC-MS analysis conducted on the aqueous extracts (EAI and EAM) and assorted fractions (FCH, FE, FB, and FA) revealed the presence of diverse chemical families encompassing alcohols, acids, terpenes, steroids, and phenolic compounds. The components identified in the investigated samples, including trans-ascaridol glycol, palmitic acid, phenol, octadecadienoic acid, isoascaridol, eicosanoic acid, 2-methoxy-4-vinyl phenol, mexiletine, and thymol, are postulated as potential contributors to the observed antioxidant activity inherent in the plant extracts and fractions. Our findings highlight the remarkable antioxidant potential of Chenopodium ambrosioides, with the ethyl acetate fraction exhibiting the highest activity (IC50 = 0.54 mg/ml) in the DPPH test. In the FRAP and ABTS tests, the n-butanolic and ethyl acetate fractions demonstrated superior activity (IC50 = 4.43 mg/ml, 12.9 mg/ml and IC50 = 1.6 mg/ml, 4.54 mg/ml, respectively). Conversely, the TAC test revealed that the macerated aqueous extract displayed the highest activity (316.33 mg Eq AG/g), followed closely by the n-butanolic fraction (250.67 mg Eq AG/g). These outcomes can be attributed to the abundant presence of phenolic compounds in the n-butanolic and ethyl acetate fractions, as well as the macerated aqueous extract, playing a pivotal role in the observed antioxidant activity. Additionally, our investigation of the dermoprotective activity demonstrated robust efficacy in the ethyl acetate fraction (FE) and the n-butanolic fraction (FB) compared to the standard agents employed (ZnO and methyl salicylate). Overall, our comprehensive studies affirm that the extracts and fractions derived from C. ambrosioides manifest moderate antioxidant activities alongside significant dermoprotective potential, elucidated by the presence of phenolic compounds in moderate quantities within the plant.